7
项与 Mesenchymal Stem Cells Therapy(Mayo Clinic) 相关的临床试验A Phase II Study of Combination Treatment With Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for High-Risk and Steroid-Refractory Acute GVHD
The purpose of this study is to see if two treatments (extracorporeal photopheresis and Mesenchymal Stromal Cell (MSC) infusion, can be given safely together, and if they improve the symptoms of a Graft versus Host Disease (GvHD), a complication that can occur in people who undergo stem cell transplant.
Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair
The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of allogeneic bone marrow-derived MSCs in patients with nonhealing epitheliopathy (IRB Protocol 2020-0334). In the present study, we want to study the efficacy of this treatment on chronic epitheliopathies.
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection
The overall objective of the study is to evaluate the safety and efficacy of MSC therapy combined with best supportive care in hospitalized patients with COVID-19.
100 项与 Mesenchymal Stem Cells Therapy(Mayo Clinic) 相关的临床结果
100 项与 Mesenchymal Stem Cells Therapy(Mayo Clinic) 相关的转化医学
100 项与 Mesenchymal Stem Cells Therapy(Mayo Clinic) 相关的专利(医药)
100 项与 Mesenchymal Stem Cells Therapy(Mayo Clinic) 相关的药物交易